Distinct Neoadjuvant Chemotherapy Response and 5-Year Outcome in Patients With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Tumors That Reclassify as Basal-Type by the 80-Gene Signature.
Saved in:
| Title: | Distinct Neoadjuvant Chemotherapy Response and 5-Year Outcome in Patients With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Tumors That Reclassify as Basal-Type by the 80-Gene Signature. |
|---|---|
| Authors: | Whitworth PW; Nashville Breast Center, Nashville, TN.; Targeted Medical Education, Cupertino, CA., Beitsch PD; Targeted Medical Education, Cupertino, CA.; Dallas Surgical Group, Dallas, TX., Pellicane JV; Bon Secours Cancer Institute, Richmond, VA., Baron PL; Breast and Melanoma Specialist of Charleston, Charleston, SC.; Lenox Hill Hospital/Northwell Health, New York, NY., Lee LA; Comprehensive Cancer Center, Palm Springs, CA., Dul CL; Ascension St John Hospital Great Lakes Cancer Management Specialists, Grosse Pointe Woods, MI., Murray MK; Akron General Medical Center, Akron, OH.; Cleveland Clinic Akron General, Akron, OH., Gittleman MA; Breast Care Specialists, Allentown, PA., Budway RJ; St Clair Hospital, Pittsburgh, PA., Rahman RL; Texas Tech University, Lubbock, TX., Kelemen PR; Ashikari Breast Center, Sleepy Hollow, NY.; Zucker School of Medicine, Hofstra University, Hempstead, NY., Dooley WC; Breast Institute, University of Oklahoma Health Sciences, Oklahoma City, OK.; Stephenson Cancer Center, Oklahoma City, OK., Rock DT; Regional Breast Care, Fort Myers, FL.; Genesis Care, Fort Myers, FL., Cowan KH; Fred and Pamela Buffet Cancer Center and Eppley Institute for Research in Cancer at University of Nebraska Medical Center, Omaha, NE., Lesnikoski BA; The Breast Institute at JFK Medical Center, Atlantis, FL.; Baptist MD Anderson Cancer Center, Jacksonville, FL., Barone JL; Exempla Saint Joseph Hospital, Denver, CO.; Vail Health, Vail, CO., Ashikari AY; Zucker School of Medicine, Hofstra University, Hempstead, NY.; Northwell Health Physician Partners, Mount Kisco, NY., Dupree BB; St Mary Medical Alliance Cancer Specialists, Langhorne, PA., Wang S; Agendia Inc, Irvine, CA., Menicucci AR; Agendia Inc, Irvine, CA., Yoder EB; Agendia Inc, Irvine, CA., Finn C; Agendia Inc, Irvine, CA., Corcoran K; Agendia Inc, Irvine, CA., Blumencranz LE; Agendia Inc, Irvine, CA., Audeh W; Agendia Inc, Irvine, CA. |
| Corporate Authors: | NBRST Investigators Group |
| Source: | JCO precision oncology [JCO Precis Oncol] 2022 Apr; Vol. 6, pp. e2100463. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35476550 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Distinct Neoadjuvant Chemotherapy Response and 5-Year Outcome in Patients With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Tumors That Reclassify as Basal-Type by the 80-Gene Signature. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Whitworth+PW%22">Whitworth PW</searchLink>; Nashville Breast Center, Nashville, TN.; Targeted Medical Education, Cupertino, CA.<br /><searchLink fieldCode="AU" term="%22Beitsch+PD%22">Beitsch PD</searchLink>; Targeted Medical Education, Cupertino, CA.; Dallas Surgical Group, Dallas, TX.<br /><searchLink fieldCode="AU" term="%22Pellicane+JV%22">Pellicane JV</searchLink>; Bon Secours Cancer Institute, Richmond, VA.<br /><searchLink fieldCode="AU" term="%22Baron+PL%22">Baron PL</searchLink>; Breast and Melanoma Specialist of Charleston, Charleston, SC.; Lenox Hill Hospital/Northwell Health, New York, NY.<br /><searchLink fieldCode="AU" term="%22Lee+LA%22">Lee LA</searchLink>; Comprehensive Cancer Center, Palm Springs, CA.<br /><searchLink fieldCode="AU" term="%22Dul+CL%22">Dul CL</searchLink>; Ascension St John Hospital Great Lakes Cancer Management Specialists, Grosse Pointe Woods, MI.<br /><searchLink fieldCode="AU" term="%22Murray+MK%22">Murray MK</searchLink>; Akron General Medical Center, Akron, OH.; Cleveland Clinic Akron General, Akron, OH.<br /><searchLink fieldCode="AU" term="%22Gittleman+MA%22">Gittleman MA</searchLink>; Breast Care Specialists, Allentown, PA.<br /><searchLink fieldCode="AU" term="%22Budway+RJ%22">Budway RJ</searchLink>; St Clair Hospital, Pittsburgh, PA.<br /><searchLink fieldCode="AU" term="%22Rahman+RL%22">Rahman RL</searchLink>; Texas Tech University, Lubbock, TX.<br /><searchLink fieldCode="AU" term="%22Kelemen+PR%22">Kelemen PR</searchLink>; Ashikari Breast Center, Sleepy Hollow, NY.; Zucker School of Medicine, Hofstra University, Hempstead, NY.<br /><searchLink fieldCode="AU" term="%22Dooley+WC%22">Dooley WC</searchLink>; Breast Institute, University of Oklahoma Health Sciences, Oklahoma City, OK.; Stephenson Cancer Center, Oklahoma City, OK.<br /><searchLink fieldCode="AU" term="%22Rock+DT%22">Rock DT</searchLink>; Regional Breast Care, Fort Myers, FL.; Genesis Care, Fort Myers, FL.<br /><searchLink fieldCode="AU" term="%22Cowan+KH%22">Cowan KH</searchLink>; Fred and Pamela Buffet Cancer Center and Eppley Institute for Research in Cancer at University of Nebraska Medical Center, Omaha, NE.<br /><searchLink fieldCode="AU" term="%22Lesnikoski+BA%22">Lesnikoski BA</searchLink>; The Breast Institute at JFK Medical Center, Atlantis, FL.; Baptist MD Anderson Cancer Center, Jacksonville, FL.<br /><searchLink fieldCode="AU" term="%22Barone+JL%22">Barone JL</searchLink>; Exempla Saint Joseph Hospital, Denver, CO.; Vail Health, Vail, CO.<br /><searchLink fieldCode="AU" term="%22Ashikari+AY%22">Ashikari AY</searchLink>; Zucker School of Medicine, Hofstra University, Hempstead, NY.; Northwell Health Physician Partners, Mount Kisco, NY.<br /><searchLink fieldCode="AU" term="%22Dupree+BB%22">Dupree BB</searchLink>; St Mary Medical Alliance Cancer Specialists, Langhorne, PA.<br /><searchLink fieldCode="AU" term="%22Wang+S%22">Wang S</searchLink>; Agendia Inc, Irvine, CA.<br /><searchLink fieldCode="AU" term="%22Menicucci+AR%22">Menicucci AR</searchLink>; Agendia Inc, Irvine, CA.<br /><searchLink fieldCode="AU" term="%22Yoder+EB%22">Yoder EB</searchLink>; Agendia Inc, Irvine, CA.<br /><searchLink fieldCode="AU" term="%22Finn+C%22">Finn C</searchLink>; Agendia Inc, Irvine, CA.<br /><searchLink fieldCode="AU" term="%22Corcoran+K%22">Corcoran K</searchLink>; Agendia Inc, Irvine, CA.<br /><searchLink fieldCode="AU" term="%22Blumencranz+LE%22">Blumencranz LE</searchLink>; Agendia Inc, Irvine, CA.<br /><searchLink fieldCode="AU" term="%22Audeh+W%22">Audeh W</searchLink>; Agendia Inc, Irvine, CA. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22NBRST+Investigators+Group%22">NBRST Investigators Group</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101705370%22">JCO precision oncology</searchLink> [JCO Precis Oncol] 2022 Apr; Vol. 6, pp. e2100463. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Clinical+Oncology%22">American Society of Clinical Oncology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101705370 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2473-4284 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224734284%22">24734284 </searchLink><i>NLM ISO Abbreviation: </i>JCO Precis Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35476550 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1200/PO.21.00463 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e2100463 Titles: – TitleFull: Distinct Neoadjuvant Chemotherapy Response and 5-Year Outcome in Patients With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Tumors That Reclassify as Basal-Type by the 80-Gene Signature. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Whitworth PW – PersonEntity: Name: NameFull: Beitsch PD – PersonEntity: Name: NameFull: Pellicane JV – PersonEntity: Name: NameFull: Baron PL – PersonEntity: Name: NameFull: Lee LA – PersonEntity: Name: NameFull: Dul CL – PersonEntity: Name: NameFull: Murray MK – PersonEntity: Name: NameFull: Gittleman MA – PersonEntity: Name: NameFull: Budway RJ – PersonEntity: Name: NameFull: Rahman RL – PersonEntity: Name: NameFull: Kelemen PR – PersonEntity: Name: NameFull: Dooley WC – PersonEntity: Name: NameFull: Rock DT – PersonEntity: Name: NameFull: Cowan KH – PersonEntity: Name: NameFull: Lesnikoski BA – PersonEntity: Name: NameFull: Barone JL – PersonEntity: Name: NameFull: Ashikari AY – PersonEntity: Name: NameFull: Dupree BB – PersonEntity: Name: NameFull: Wang S – PersonEntity: Name: NameFull: Menicucci AR – PersonEntity: Name: NameFull: Yoder EB – PersonEntity: Name: NameFull: Finn C – PersonEntity: Name: NameFull: Corcoran K – PersonEntity: Name: NameFull: Blumencranz LE – PersonEntity: Name: NameFull: Audeh W IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2022 Apr Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 2473-4284 Numbering: – Type: volume Value: 6 Titles: – TitleFull: JCO precision oncology Type: main |
| ResultId | 1 |